Nalanda India Fund bought shares of Thyrocare shares in two bulk deals, of 1.7 million shares and 1.09 million shares each.   

Thyrocare Technologies has seen its share price rise over the past week, as well as higher delivery volumes as the company emerged as one of the lab companies approved for coronavirus testing - ICMR has so far given Thyrocare's lab in Navi Mumbai recognized status for coronavirus tests. It is one of nine labs in Mumbai that will be testing coronavirus cases. 

While the government has capped price of tests at Rs. 4,500, emerging cheaper Made in India test kits have made potential margins possible for the firm as it scales up tests for patients.